用户名: 密   码:
注册 | 忘记密码?
专利详细信息
专利号
US2012263716A1
专利标题 METHOD OF TREATING CANCERS AND A PHARMACEUTICAL COMPOSITION THAT MAY BE USED IN PRACTICING SAID METHOD
专利权人 DAIICHI SANKYO CO LTD [JP];
发明人 FUJIWARA KOSAKU [JP]; SHIMAZAKI NAOMI [JP];
申请号 US201213527002
申请日 2012/6/19
公开日 2012/10/18
优先权号 JP20060031791 20060209
US20080221019 20080730
WO2007JP52178 20070208
IPC A61K0031427; A61K003144; A61K0031502; A61K0031517; A61K00315377; A61K0039395; A61P003500; A61P003502;
专利类型
法律状态查询 查看法律状态


The method of treating a person having a cancer selected from carcinoma, sarcoma or hematopoietic cancer by administering (a) an effective amount of at least one anti-cancer drug selected from the group consisting of an epidermal growth factor receptor (EGFR) inhibitor, a vascular endothelial growth factor receptor (VEGFR) inhibitor and a Raf kinase inhibitor and (b) an effective amount of 5-(4-(6-(4-amino-3,5-dimethyl-phenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy)-benzyl)-thiazolidine-2,4-dione.dihydrochloride provided that said carcinoma is not lung cancer when an EGFR inhibitor is erlotinib. The invention also provides a pharmaceutical composition that may be used in practicing said method.
专利号专利名称专利权人优先权号
NZ570381A Anti-cancer pharmaceutical composition DAIICHI SANKYO CO LTD; JP20060031791
WO2007JP52178
没有相关的数据
引证图片
暂无附图

注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。

上传 | 编辑 | 标注(0) | 下载专利全文 | 收藏